Conflict of Interest Issues when Engaging Interest-Holders in Health Guideline Development: A Scoping Review
Campbell Systematic Reviews: Better Evidence for a Better World · 2026-09 · 22 (4)
DOI: 10.1177/18911803261492338 ↗Kurz gefasst
Scoping Review in der Zeitschrift Campbell Systematic Reviews: Better Evidence for a Better World, online erschienen am 13.11.2026. Verfasst von Joanne Khabsa und 16 weiteren Autor:innen. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background: “A conflict of interest (COI) exists when a past, current, or expected interest creates a significant risk of inappropriately influencing an individual’s judgment, decision, or action when carrying out a specific duty.” To ensure the integrity and transparency of the guideline development process, there is a need for the declaration, management and reporting of COI of all contributors, including interest-holders. This scoping review is part of a series of four related reviews by the MuSE (formerly Multi-Stakeholder Engagement) Consortium that informed the development of guidance for interest-holder engagement in guideline development, the GIN-McMaster Guideline Development Checklist Extension for Interest-holder Engagement. The three other reviews address respectively: a) guidance for interest-holder engagement in guideline development, b) barriers and facilitators to interest-holder engagement in guideline development, and c) the impact of interest-holder engagement on guideline development. Objectives: To scope the existing literature on COI issues when engaging interest-holders in guideline development. Search methods: We conducted one comprehensive search for the four related reviews by the MuSE Consortium. We searched the following databases: MEDLINE (OVID), CINAHL (EBSCO), EMBASE (OVID), PsycInfo (OVID), SCOPUS and Sociological Abstracts databases, without limits for date, study design, or language. We also searched websites of agencies and organizations that engage interest-holders. We invited members of the MuSE Consortium to suggest additional grey literature. Selection criteria: We pre-defined selection criteria. Studies needed to address any of the 10 categories of interest-holders identified by the MuSE Consortium, except for principal investigators, for whom COI issues have been extensively assessed in the literature. These include patients, caregivers, and patient advocates/organizations; payers/purchasers of health services; payers of research; peer-reviewed journal editors; policymakers; product makers; program managers; providers of health care; the public. Studies needed to address one of the following aspects of COI, in the context of interest-holder engagement in health guideline development: (1) types of interest-holders’ COI and their prevalence, (2) impact of interest-holders’ COI on guideline development, (3) approaches for declaration, management, and reporting of COI, (4) COI considerations related to the process of selecting interest-holders to participate. We included qualitative, quantitative, mixed-methods studies, and conceptual papers. We excluded editorials, commentaries, proposals, guideline handbooks, study protocols and conference abstracts. We conducted all stages of screening in duplicate and independently. Data collection and analysis: Two reviewers independently charted data in duplicate on study objective(s), design, participants, types of interest-holders studied, topics of guideline development covered, level of engagement, and results. We summarized the findings narratively, assisted by tabulation. Main results: From 31,500 unique citations, we judged 730 full texts as potentially eligible. Of these, we included ten eligible studies. Types of COI for interest-holders as individuals included both financial (e.g. industry funding) and non-financial COI (e.g. when a patient’s opinion is affected by that of their treating physician if both are serving on the same guideline panel). Two studies reported that patients’ own experiences of the condition represent ‘vested’ or ‘inherent’ interests that may bias their views. Other types of COI relate to the academic or professional specialty of certain interest-holder groups. Only one study reported on the prevalence of COI and found that 44% (70/158) of advocacy and professional organizations submitting public comments to CDC draft guidelines reported receiving funding from the industry; however, funding status was not known for 15% of organizations. In terms of the impact of COI, one study found an association between industry funding of interest-holders’ organizations and their support for the guidelines and specific recommendations. In terms of management, one study noted the importance of ‘independent, neutral role of the reviewers’ considering the ‘vested interests’ of advisory group members. In relation to the selection process, a framework for patient engagement proposed that patients be engaged in assessing the guideline development group members’ COI, and a guidance paper highlighted the need to select persons with the ability to consider the evidence and make recommendations in a way that departs from preconceived views or self-interests. Authors’ conclusions: We identified a limited number of studies on the COI of interest-holders engaged in guidelines, primarily focusing on patients or the public. While both financial and non-financial COI may exist, the available evidence suggests financial COI may have a more direct impact on recommendations. A number of strategies are being used for the management of COI, but none of them has been evaluated. It is essential for guideline developers to clearly define what constitutes a COI for interest-holders engaged in guideline development. We argue that patients’ experiences should not be considered as COI. Instead, lived experience should be recognized as a legitimate interest that contributes valuable insights to the development of guidelines.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Khabsa, J., Petkovic, J., Magwood, O., Lytvyn, L., Atwere, P., Riddle, A., Campbell, P., Chang, S., Katikireddi, S. V., Nasser, M., Skoetz, N., Merner, B., Garcia, A. J., Limburg, H., Guise, J., Tugwell, P., & Akl, E. A. (2026). Conflict of Interest Issues when Engaging Interest-Holders in Health Guideline Development: A Scoping Review. Campbell Systematic Reviews: Better Evidence for a Better World, 22(4). https://doi.org/10.1177/18911803261492338
Vancouver
Khabsa J, Petkovic J, Magwood O, Lytvyn L, Atwere P, Riddle A, et al. Conflict of Interest Issues when Engaging Interest-Holders in Health Guideline Development: A Scoping Review. Campbell Systematic Reviews: Better Evidence for a Better World. 2026;22(4). doi:10.1177/18911803261492338
BibTeX
@article{Khabsa2026,
author = {Khabsa, Joanne and Petkovic, Jennifer and Magwood, Olivia and Lytvyn, Lyubov and Atwere, Pearl and Riddle, Alison and Campbell, Pauline and Chang, Stephanie and Katikireddi, Srinivasa Vittal and Nasser, Mona and Skoetz, Nicole and Merner, Bronwen and Garcia, Alejandra Jaramillo and Limburg, Heather and Guise, Jeanne-Marie and Tugwell, Peter and Akl, Elie A.},
title = {Conflict of Interest Issues when Engaging Interest-Holders in Health Guideline Development: A Scoping Review},
journal = {Campbell Systematic Reviews: Better Evidence for a Better World},
year = {2026},
volume = {22},
number = {4},
doi = {10.1177/18911803261492338}
}
EUVIMED